Welcome to our dedicated page for Bioceres Crop Solutions SEC filings (Ticker: BIOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bioceres Crop Solutions Corp. (NASDAQ: BIOX) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Bioceres files annual reports on Form 20-F and frequent current reports on Form 6-K, presenting financial statements in accordance with International Financial Reporting Standards (IFRS) and expressing figures in U.S. dollars.
Through these filings, readers can review segment-level financial information for Bioceres’ Crop Protection, Seed and Integrated Products, and Crop Nutrition businesses, along with consolidated statements of comprehensive income, financial position and cash flows. The documents also discuss non-IFRS measures such as Adjusted EBITDA and provide reconciliations and explanations referenced in the company’s earnings releases.
Bioceres’ Form 6-K submissions include earnings press releases for quarterly and full-year periods, subsidiary financial statements, and materials for its Annual General Meeting, such as notices and proxy documents. Other 6-Ks describe governance and management changes, including appointments and resignations of directors and executives, and the designation of a principal accounting officer.
The filings also detail financing arrangements and legal matters, such as secured and convertible note purchase agreements, corporate bonds and amendments to these instruments. In a November 2025 Form 6-K, Bioceres reported receiving a Declaration of Acceleration of Notes from certain noteholders and disclosed related litigation, while stating that it disputes the alleged defaults and intends to defend its position.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered tools can be used to summarize lengthy documents, highlight key segment data, and help readers quickly locate information on topics such as revenue composition, debt instruments, equity structure and governance disclosures.
Bioceres Crop Solutions Corp. received an updated ownership filing from the Draco group of investors. In this Amendment No. 2 to a Schedule 13G, DRACO I SPC LTD, DRACO Capital Investment Management Company Ltd, and DRACO I EVENT OPPORTUNITY SEGREGATED PORTFOLIO each report beneficial ownership of 0 ordinary shares, or 0.0% of Bioceres’ outstanding ordinary shares.
The Draco entities state they have no sole or shared power to vote or dispose of any Bioceres shares and confirm they now own 5 percent or less of the class. They also certify that any securities previously held were not acquired to change or influence control of Bioceres.
Agriculture Investment Group Corp. (AIGC) and Granosur Holding Limited have amended their beneficial ownership report for Bioceres Crop Solutions Corp. They now beneficially own 9,786,395 ordinary shares, equal to 15.42% of Bioceres, based on 63,478,813 shares outstanding as of September 30, 2025.
The holdings consist of 3,986,395 shares held by AIGC and 5,800,000 shares held by Granosur, with shared voting and dispositive power over these positions. AIGC sold an aggregate 908,274 shares in open‑market transactions in January and early February 2026 at average prices between $0.60 and $1.23 per share, reducing its stake. The reporting persons state they have no current specific plans for corporate actions regarding Bioceres but may reconsider their position over time.
Bioceres Crop Solutions Corp. received an updated ownership report on its ordinary shares. An investor group including Fourth Sail Capital LP, Fourth Sail Capital US LP, Fourth Sail Discovery LLC, Fourth Sail Long Short LLC, Tordesilhas Capital Gestora De Recursos Ltda., and individual filer Ariel Merenstein collectively reports beneficial ownership of 4,331,096 ordinary shares, representing 6.82% of the class.
The filing shows no sole voting power for any reporting person, but shared voting and dispositive power over these shares is allocated among the entities in the group. The investors certify that the shares were not acquired and are not held for the purpose of changing or influencing control of Bioceres, indicating a passive investment intent.
Bioceres Crop Solutions Corp. investor Jasper Lake Ventures One LLC and principal Noah Kolatch report a 12.13% beneficial stake in the company’s ordinary shares. They may be deemed to beneficially own 8,710,707 ordinary shares, including 397,000 shares currently held and additional shares issuable upon conversion of notes within 60 days.
The ownership percentage is calculated against 63,478,813 ordinary shares outstanding as of
On
Bioceres Crop Solutions Corp. reported that a UCC foreclosure sale was held on January 20, 2026 on collateral pledged by Pro Farm Group, Inc. and Pro Farm Michigan Manufacturing, LLC under notes issued in August 2022 and amended in June 2025. The only qualified bid came from PFG Holdings Corp, a joint venture formed by the noteholders, which made a credit bid of $15 million in notes and was declared the winning bidder.
The sale was conducted virtually with representatives of the company, the noteholders, and their respective counsel present. Bioceres states that it disputes the alleged defaults that led to the foreclosure and the commercial reasonableness of the sale, and it reserves all rights and remedies.
Bioceres Crop Solutions Corp. submitted a Form 6-K as a foreign private issuer for November 2025. The filing mainly serves as a cover document for unaudited interim condensed consolidated financial statements as of September 30, 2025 and June 30, 2025, and for the three-month periods ended September 30, 2025 and 2024, which are included as Exhibit 99.1. The Form 6-K also states that this information is incorporated by reference into the company’s existing registration statements on Form F-3 and multiple Form S-8 registrations.
Bioceres Crop Solutions (BIOX) reported that noteholders delivered a Declaration of Acceleration on its convertible and non-convertible notes on November 10, 2025, alleging uncured defaults. On November 11, 2025, these holders filed a lawsuit in New York Supreme Court seeking payment in full under the note agreements.
The company disputes the allegations and the purported effect of the acceleration and says it will vigorously defend its position. The filing also notes that this 6-K is incorporated by reference into existing Form F-3 and S-8 registration statements.
Bioceres Crop Solutions (BIOX) filed its annual report (Form 20-F) for the year ended June 30, 2025. The company highlights a reshaped debt profile and liquidity pressures following note amendments and covenant breaches.
Convertible Notes total $67,868,227 at 15% interest (5% cash, 10% paid in kind) with maturity extended to August 31, 2027. Non-Convertible Notes total $29,081,233 at 19% interest (14% cash, 5% paid in kind) with monthly amortization. Due to covenant breaches as of June 30, 2025, $102.3 million of notes were reclassified as current liabilities. Total indebtedness was $260.2 million, with $222.0 million maturing in the fiscal year ending June 30, 2026. Management’s financial statements include a statement of substantial doubt about the company’s ability to continue as a going concern.
The report also notes a change-of-control event at Bioceres Group Limited on June 16, 2025, creating termination rights under the HB4 licensing agreement. BIOX transitioned HB4 from direct seed sales to a licensing model. 63,228,239 ordinary shares were outstanding as of June 30, 2025.
FAQ
What is the current stock price of Bioceres Crop Solutions (BIOX)?
What is the market cap of Bioceres Crop Solutions (BIOX)?
